X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4%
Thu, 30 May

SUN PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m69,77177,40271,639-7.4%2.7%
Other incomeRs m3,0281,9312,81545.8%-7.0%
TurnoverRs m72,79979,33374,455-6.1%2.3%
ExpensesRs m52,93655,87361,47110.0%16.1%
Gross profitRs m16,83521,52910,168-52.8%-39.6%
DepreciationRs m4,5524,7114,541-3.6%-0.3%
InterestRs m1,5541,4481,5003.6%-3.4%
Profit before taxRs m13,75617,3016,942-59.9%-49.5%
TaxRs m-1,7672,709-288-110.6%
Profit after taxRs m15,52314,5927,231-50.4%-53.4%
Gross profit margin%24.127.814.2
Effective tax rate%-12.815.7-4.1
Net profit margin%21.318.49.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 2.7% on a year-on-year (YoY) basis. The expenses were up by 16.1% YoY during the same period.
  • The company's operating profit declined by 39.6% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 14.2% in 4QFY19 as against 24.1% in 4QFY18.
  • Depreciation charges declined by 0.3% and finance costs declined by 3.4% YoY, respectively.
  • Other income declined by 7.0% YoY during the quarter.
  • Net profit for the quarter declined by 53.4% YoY. Net profit margins during the quarter declined from 21.3% in 4QFY18 to 9.7% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 7.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 10.0% QoQ during the same period.
  • The company's operating profit declined by 52.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 14.2% in 4QFY19 as against 27.8% in 3QFY18.
  • Net profit for the quarter declined by 50.4% QoQ, while net profit margins declined from 18.4% in 3QFY18 to 9.7% in 4QFY19.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 494.8 to Rs 418.3, registering a Loss of Rs 76.5 or around 15.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,333.1 (up 0.2%). Over the last one year it has moved up from 13,111.9 to 13,333.1, a gain of 221 points (up 1.7%).

Overall, the S&P BSE SENSEX is up 13.6% over the year.

Current Valuations

At the current price of Rs 418.3, the price to earnings (P/E) ratio of SUN PHARMA stands at 31.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.6 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jul 19, 2019 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS